This funding opportunity supports projects that translate scientific and engineering developments in imaging, data science, and spectroscopic technologies into validated in vivo imaging systems addressing cancer biology, risk, diagnosis, treatment, or disease status. The grant encourages collaborations between academic and industrial partners and allows optional clinical trials to validate these technologies.
Eligible applicants include a wide range of U.S.-based organizations such as nonprofits, for-profits, small businesses, tribal governments, state and local governments, and institutions of higher education. Specific IRS status and organizational types apply.
